Kyivstar Group Ltd. filings document its status as a foreign private issuer with Form 20-F annual reporting and Form 6-K current reports. The disclosures cover audited and interim financial statements, earnings releases, non-IFRS measure updates, operating results for telecommunications and digital services, and public-company reporting following its Nasdaq listing.
Kyivstar’s regulatory filings also address material events and corporate actions, including completed digital-platform acquisitions such as Tabletki.ua, registration-statement excerpts tied to common-share offerings by selling shareholders, capital-structure disclosures, shareholder voting matters and annual general meeting materials. Governance, board-election matters, risk disclosures and security-structure information appear through the company’s annual report, current reports and related exhibits.
Kyivstar Group Ltd. has updated its prospectus to cover the resale of up to 6,768,098 common shares and up to 7,666,629 additional common shares issuable upon exercise of outstanding public warrants at an exercise price of $11.50 per share.
At the same time, Kyivstar has completed the acquisition of 100% of Tabletki.ua, a leading Ukrainian online platform for healthcare products, for aggregate consideration of approximately USD 160 million, paid in Ukrainian Hryvna in Ukraine. Kyivstar’s common shares trade on the Nasdaq Global Select Market under the symbol “KYIV”, with a last reported sale price of $12.25 per share on February 9, 2026.
Kyivstar Group Ltd. has completed the acquisition of 100% of Ukrainian online healthcare marketplace Tabletki.ua for USD 160 million, paid entirely in Ukrainian hryvna in Ukraine. The deal closed concurrently with the signing of the definitive agreement.
Tabletki.ua partners with more than 14,000 pharmacies across Ukraine and facilitated an average of 14 million online bookings per month in 2025. Bookings carried a gross merchandise value of UAH 45 billion (USD 1,056 million) for 2024 and UAH 57.3 billion (USD 1,191 million) for the 12 months ended September 30, 2025.
Based on unaudited management accounts as of September 30, 2025, Tabletki.ua generated EBITDA of USD 24 million and net profit of USD 20 million, implying a price-to-earnings multiple of 8.0x. Kyivstar positions the acquisition as expanding its digital healthcare offering alongside assets such as Helsi and Uklon and describes it as immediately earnings accretive with material synergy potential.
Kyivstar Group Ltd. reports that its principal shareholder VEON Amsterdam B.V. and other holders have priced a secondary public offering of 12,500,000 common shares at USD 10.50 per share. The company is not selling any shares and will not receive proceeds.
The selling shareholders granted underwriters a 30-day option to buy up to an additional 1,875,000 shares at the same price, less underwriting discounts and commissions. The offering is expected to close on February 2, 2026, subject to customary conditions, under an effective Form F-1 registration statement.
Kyivstar Group Ltd. shareholders are offering 12,500,000 common shares at $10.50 per share in a Nasdaq-listed secondary sale. All shares are sold by VEON Amsterdam and other selling shareholders, who will receive the approximately $131.3 million in gross proceeds; Kyivstar receives none.
The underwriters may buy up to an additional 1,875,000 shares within 30 days. Kyivstar operates Ukraine’s largest mobile network, serving over 22.5 million mobile and 1.2 million broadband customers, and reported 2024 profit of $283 million and Adjusted EBITDA of $515 million with margins above 50%.
Preliminary 2025 estimates point to revenue and Adjusted EBITDA growth of about 24–26% in U.S. dollars, alongside heavy capital spending with Capex Intensity of roughly 29–31%. The prospectus highlights significant risks from the ongoing war in Ukraine, infrastructure damage, nationalization laws, sanctions-related constraints, and going concern uncertainties flagged by auditors.
Kyivstar Group Ltd. has an effective resale registration covering up to 6,768,098 common shares and up to 7,666,629 common shares issuable upon exercise of outstanding public warrants at an exercise price of $11.50 per share. A related Form F-1 filing describes a proposed secondary public offering of 12,500,000 common shares by VEON Amsterdam B.V. and other selling shareholders, with a 30‑day option for underwriters to purchase up to an additional 1,875,000 shares; the company itself is not selling shares in that offering. Preliminary unaudited 2025 estimates indicate revenue growth of 24%–26% year over year in U.S. dollars, with Adjusted EBITDA also growing 24%–26% and Capex Intensity in a 29%–31% range. Management emphasizes these figures are preliminary, unaudited, based on incomplete closing procedures and subject to change, and highlights extensive risks, including the ongoing war in Ukraine, sanctions, regulatory uncertainty, and market volatility.
Kyivstar Group Ltd. reports preliminary 2025 results alongside news of a planned secondary share sale by existing owners. Selling shareholders, including VEON Amsterdam B.V., plan to offer 12,500,000 common shares, with underwriters holding a 30-day option for up to 1,875,000 additional shares. The company itself will not sell shares in this offering.
For the year ended December 31, 2025, Kyivstar estimates revenue growth of roughly 24–26% in U.S. dollars compared with 2024, with Adjusted EBITDA expected to grow at a similar 24–26% range. Capex Intensity for 2025 is projected between 29% and 31%. These figures are unaudited, subject to completion of year-end closing procedures and audit, and are described as inherently uncertain. The company also highlights extensive risk factors, notably the ongoing war in Ukraine, regulatory and currency constraints, and broader macroeconomic, competitive and cyber risks that could materially affect future performance.
Kyivstar Group Ltd. has filed an F-1 for the resale of 12,500,000 common shares by VEON Amsterdam B.V. and other selling shareholders, with an underwriters’ option for up to 1,875,000 additional shares. The company is not selling shares and will not receive offering proceeds, though it will cover offering expenses other than underwriting fees.
Kyivstar is a leading Ukrainian telecom and digital services provider with over 22.5 million mobile customers and 1.2 million broadband subscribers as of September 30, 2025. For 2024 and the nine months ended September 30, 2025, it reported profit of $283 million and $34 million, and Adjusted EBITDA of $515 million and $477 million, with Adjusted EBITDA margins of 56% and 57%.
Preliminary 2025 estimates indicate revenue and Adjusted EBITDA growth of 24%–26% year over year and Capex Intensity of 29%–31%. The filing highlights significant risks from the ongoing war in Ukraine, potential nationalization measures, sanctions-related constraints, and a going concern emphasis in the auditor’s opinion. Kyivstar is an emerging growth company, a foreign private issuer and a controlled company, with VEON expected to hold about 84.4% of shares after the offering.
Kyivstar Group Ltd. is updating how it calculates its non-IFRS metric Equity Free Cash Flow for the third quarter of 2025. The company explains that the earlier Q3 earnings release included a one-time cash inflow of $134 million from a shares issuance in this metric.
To improve comparability between periods, Kyivstar now says Equity Free Cash Flow should exclude cash inflows from proceeds from shares issuance. Using this updated definition, Equity Free Cash Flow before licenses and leases was $40 million for the three months and $203 million for the nine months ended September 30, 2025, and $239 million as of that date. Equity Free Cash Flow after licenses and leases was $31 million for the three months and $176 million for the nine months ended September 30, 2025.
Kyivstar Group Ltd. is registering up to 6,768,098 common shares for resale and up to 7,666,629 additional shares issuable upon exercise of outstanding public warrants. The resale shares include 6,010,353 shares issued to SPAC sponsors and 757,745 shares issued to investors who agreed not to redeem their Cohen Circle shares before the business combination. The company will not receive proceeds from any shareholder resales, but could receive up to $88,166,233.50 if all warrants are exercised for cash at $11.50 per share.
Kyivstar operates Ukraine’s leading mobile and broadband network, serving over 23 million mobile customers and 1.1 million broadband subscribers as of December 31, 2024. For 2024 it reported profit of $283 million and Adjusted EBITDA of $515 million, with Adjusted EBITDA margin of 56%. The nine months ended September 30, 2025 showed profit of $34 million, affected by a one-time listing expense of $162 million, and Adjusted EBITDA of $477 million.
The filing highlights severe risks from the ongoing war in Ukraine, including physical damage to network assets, higher energy costs, restrictions on moving cash abroad and potential nationalization measures. About 5.3% of the combined telecom network had been damaged or destroyed, of which 82% was restored, and roughly 6% of the network was non-functional in Russian-occupied territories as of December 31, 2024. Kyivstar spent approximately UAH 1,866.8 million (about $45.3 million) in 2024 on generators, batteries and other resilience measures.
Kyivstar’s auditors included an emphasis on substantial doubt about its ability to continue as a going concern because of the war, sanctions exposure around certain VEON‑related beneficial owners, and broader macro and legal uncertainties in Ukraine. VEON beneficially owns about 89.6% of outstanding shares, making Kyivstar a controlled company under Nasdaq rules and allowing it to rely on reduced corporate governance requirements. Kyivstar is also an emerging growth company and a foreign private issuer, which further reduces some U.S. reporting and governance obligations.